Solarvest BioEnergy Inc.
SVSH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 100.25% | -80.95% | -71.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 100.25% | -80.95% | -71.43% |
| Cost of Revenue | -- | -- | 358.58% | 2,046.88% | 2,047.50% |
| Gross Profit | -- | -- | -743.90% | -2,386.23% | -2,385.51% |
| SG&A Expenses | -54.24% | -46.86% | -25.62% | 59.46% | 138.98% |
| Depreciation & Amortization | -33.57% | -32.10% | -38.96% | -39.04% | -39.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -68.33% | -67.86% | -28.97% | 3.08% | 26.92% |
| Operating Income | 68.32% | 67.85% | 33.17% | -3.22% | -27.11% |
| Income Before Tax | 67.42% | 67.22% | 34.89% | 4.74% | -32.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 67.42% | 67.22% | 34.89% | 4.74% | -32.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.42% | 67.22% | 34.89% | 4.74% | -32.90% |
| EBIT | 68.32% | 67.85% | 33.17% | -3.22% | -27.11% |
| EBITDA | 70.01% | 69.54% | 32.89% | -5.67% | -31.17% |
| EPS Basic | 68.64% | 68.81% | 39.33% | 11.20% | -25.88% |
| Normalized Basic EPS | 63.43% | 64.21% | 35.15% | 4.08% | -22.38% |
| EPS Diluted | 68.64% | 68.81% | 39.33% | 11.20% | -25.88% |
| Normalized Diluted EPS | 63.43% | 64.21% | 35.15% | 4.08% | -22.38% |
| Average Basic Shares Outstanding | 3.54% | 5.99% | 8.58% | 8.44% | 6.04% |
| Average Diluted Shares Outstanding | 3.54% | 5.99% | 8.58% | 8.44% | 6.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
